overzicht

Protein findings open new avenues to understanding and treatment of schizophrenia

Gepubliceerd: 10-11-2015

Stem cells from adult schizophrenia patients form new proteins more slowly than those from healthy people, according to new research.

The findings are enhancing understanding of how schizophrenia affects the workings of the brain, and open the way to new approaches for future drug therapies.

Involving scientists from Griffith University’s Eskitis Institute for Drug Discovery, the Royal College of Surgeons in Ireland and University College Dublin, the research is published online in the journal Translational Psychiatry.

According to the Eskitis Institute’s Professor Emeritus Alan Mackay-Sim, analysis of almost 1000 proteins in patients’ stem cells indicated their cellular machinery for making new proteins was reduced, with the rate of protein synthesis greatly impaired.

“Proteins are the workhorses of all cells and make up most of a cell’s structure and functions,” says Professor Mackay-Sim, whose Griffith team included Dr Yongjun Fan and Mr Nicholas Matigian.

“Cells live in a very dynamic environment and protein synthesis, which is so important for brain development, function and learning, is impacted by environmental and genetic factors.

“It is now becoming clearer that many small genetic variants are linked because they share control of cellular functions, in this case protein synthesis.

“If protein synthesis is altered even slightly, many cell functions would also be subtly changed. This could affect brain development and adult brain function in schizophrenia.

“This work helps make sense of the rapid advances in genetics that have identified hundreds of risk genes for schizophrenia.”

Interestingly, the same issue of Translational Psychiatry reports contrasting findings from a second research collaboration, also involving Professor Mackay-Sim, University College Dublin and a laboratory in the US.

This study used a different kind of stem cell generated from people with schizophrenia, namely induced pluripotent stem cells.

These are genetically engineered from skin cells and stimulated to turn into stem cells resembling the neural progenitor cells that give rise to the brain in the developing human embryo.

When the proteins from these cells were analysed, the patients’ cells were found to have more protein-making machinery and also made proteins more quickly than cells from healthy controls.

“However, while on the surface this seems like a contradiction, the two studies support each other by showing that the regulation of protein synthesis is subtly disturbed in the cells of people with schizophrenia,” says Professor Mackay-Sim.

“The studies seem to show that the on/off switch for protein synthesis may be altered in different cells or at different life stages in schizophrenia.

“This provides many ways in which brain development and function is altered in schizophrenia, and many routes for the ways in which genes and the environment interact to cause schizophrenia.”

Bron: Griffith University

Overig nieuws


18-07-2025 - Hersenstimulatie helpt bij OCD
15-07-2025 - NZa maakt nieuwe tarieven ggz bekend
15-07-2025 - Zorgen over toename ADHD
14-07-2025 - Dieren in het nieuws
14-07-2025 - De meerwaarde van psychotherapie met paarden
14-07-2025 - Blijvende littekens: hoe jeugdtrauma's doorwerken in het volwassen leven
14-07-2025 - Het Aardvarken
14-07-2025 - De autonome route, zelfbeschikking over het levenseinde
14-07-2025 - Ben ik echt?
14-07-2025 - De podcasts
14-07-2025 - De bibliotheek
10-07-2025 - Onderzoek MIND: AI voorziet in behoefte
10-07-2025 - Uitwerking cao gereed
09-07-2025 - Pilots voor dakloosheid bij ggz-indicatie
09-07-2025 - VR succesvol in behandeling psychoses
08-07-2025 - Pilots Groen voor Gezondheid geselecteerd
08-07-2025 - Ton Vink in bestuur De Hoop Groep
08-07-2025 - LVVP wint kort geding tegen NZa
04-07-2025 - Huisartsen zeer negatief over samenwerking met ggz
03-07-2025 - AZWA-akkoord gaat toch door
03-07-2025 - HIC’s van GGZ Oost Brabant mogelijk naar ziekenhuis Bernhoven
02-07-2025 - Tanja Berger in bestuur NVvP
01-07-2025 - Oproep richting verkiezingen: meer aandacht voor mentale gezondheid
01-07-2025 - Janna Vrijsen hoogleraar Transdiagnostische psychopathologie
30-06-2025 - Wij kijken niet mee
30-06-2025 - Hoe ziet innovatie in de jeugd-ggz er concreet uit?
30-06-2025 - POET: een online emotieregulatietherapie voor jongeren met psychische klachten
30-06-2025 - Bij jongeren veerkracht weven na trauma
30-06-2025 - A NICE DAY
30-06-2025 - Gelukkig gelabeld, van ADHD tot angststoornis: een zoektocht naar mentale gezondheid
30-06-2025 - Wachtlijsten verkort door andere aanpak lichtere problemen?

Laatste nieuws

Tagcloud


  • autisme
  • congres
  • corona
  • depressie
  • gedicht
  • jeugdzorg
  • personalia
  • recensie
  • suicide
  • verslaving

Zoeken in nieuws


Zoek

Contactgegevens

LET OP: GGZ Totaal is geen instelling voor behandeling of begeleiding. Neem daarvoor contact op met de eigen behandelaar of huisarts.
t: -
info@ggztotaal.nl

Deel deze pagina

Neem contact op


Op de hoogte blijven?


Vul uw emailadres in en ontvang gratis ons magazine!

 

 

Disclamer & privacy


Hoe gaan we met jouw gegevens om?

 

Het laatste nieuws


  • Hersenstimulatie helpt bij OCD

  • NZa maakt nieuwe tarieven ggz bekend

  • Zorgen over toename ADHD

  • Dieren in het nieuws

    van de redactie
  • De meerwaarde van psychotherapie met paarden

    door Leendert Douma

Zoeken


 

Social media


FacebookTwitterLinkedInInstagram

 

Weesperzijde 10-H   |   1091 EA Amsterdam   |  info@ggztotaal.nl   |   Webdesign PEW

Copyright 2025 - GGZ Totaal
Inloggen | Ziber Website | Design by PEW Grafisch ontwerpstudio